Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Communiqué de presse : Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies...
Communiqué de presse : Sanofi inaugure la première usine modulable de vaccins et biomédicaments au monde à Neuville-sur-Saône Sanofi inaugure la...
CP- Tolebrutinib satisfait au critère d’évaluation primaire de l’étude de phase III HERCULES ; premier et seul médicament qui a permis d’observer...
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in...
Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in...
Sanofi: Information concerning the total number of voting rights and shares - July 2024 Information concerning the total number of voting rights...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2024 Informations relatives au nombre total de droits de...
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed...
Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with...
Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients...
Press Release: Online availability of Sanofi’s half-year financial report for 2024 Online availability of Sanofi’s half-year financial report for...
Online availability of Sanofi’s half-year financial report for 2024 Paris, July 25, 2024. Sanofi announces...
Communiqué de presse : Mise en ligne du rapport financier semestriel 2024 de Sanofi Mise en ligne du rapport financier semestriel 2024 de Sanofi...
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded Sanofi Q2: strong performance with 10% sales growth;...
Communiqué de presse : Forte performance au deuxième trimestre soutenue par une croissance des ventes de 10% - Perspectives 2024 relevées ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관